Clinical Trial Update: Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma [NA]

View source ↗

Summary

A clinical trial entry indicating recruitment for a study of nanosecond pulsed field ablation to treat papillary thyroid carcinoma (T1N0M0).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillary Thyroid Carcinoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Thyroid Carcinoma | NA | Status: RECRUITING